Pro-Dex, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74265M2052
USD
40.70
3.14 (8.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Pro-Dex, Inc. stock-summary
stock-summary
Pro-Dex, Inc.
Pharmaceuticals & Biotechnology
Pro-Dex, Inc. (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through three segments: Pro-Dex, OMS and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce. The OMS segment is engaged in providing multi-axis motion control applications. In addition to Pro-Dex, the names Micro Motors and Oregon Micro Systems are used for marketing purposes as brand names. The Company provides engineering consulting services, as well as quality and regulatory consulting services, to a range of industries through EDS.
Company Coordinates stock-summary
Company Details
2361 McGaw Ave , IRVINE CA : 92614
stock-summary
Tel: 1 949 7693231
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 10 Schemes (10.98%)

Foreign Institutions

Held by 18 Foreign Institutions (1.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Nicholas Swenson
Independent Chairman of the Board
Mr. Richard Van Kirk
President, Chief Executive Officer, Chief Operating Officer, Director
Ms. Katrina Philp
Director
Mr. Raymond Cabillot
Independent Director
Mr. William Farrell
Independent Director
Mr. David Hovda
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 116 Million (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

21.44%

stock-summary
Price to Book

3.17